January 30, 2019
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
Read More
December 10, 2018
Adjusted Fibrinogen Replacement Strategy
Read More
December 10, 2018
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
Read More
December 10, 2018
A Study of TMC435 in Combination With Pegylated Interferon AlpFa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Read More
X